சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் Today - Breaking & Trending Today

Novel technology can be effective non-surgical treatment option for congenital heart disease patients


Novel technology can be effective non-surgical treatment option for congenital heart disease patients
New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
About 40,000 infants are born with CHD every year in the United States and approximately one in five CHD patients have an abnormality of their right ventricular outflow tract (RVOT) . Prior to TPV technology, CHD patients were treated with invasive procedures such as open-heart surgery or o ....

United States , Thomas Jones , Emily Henderson , Society For Cardiovascular Angiography Interventions , Drug Administration , Medtronic Harmony , Cardiovascular Angiography , Principal Investigator , Cardiac Catheterization Laboratories , Seattle Children , Congenital Heart Disease , Heart Disease , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் ஜோன்ஸ் , எமிலி ஹென்டர்சன் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் , மெதிடிறோனிக் நல்லிணக்கம் , இருதய ஆஞ்சியோகிராபி , ப்ரிந்ஸிபல் புலனாய்வாளர் , இதய வடிகுழாய் ஆய்வகங்கள் , சீட்டில் குழந்தைகள் , பிறவி இதயம் நோய் ,

Technology provides procedure efficiencies for congenital heart disease patients


 E-Mail
WASHINGTON, D.C, (April 30, 2021) - An analysis of a new international registry reveals benefits of using a longer covered stent for interventional procedures in congenital heart disease patients with Sinus Venosus Atrial Septal Defect (SVASD). The study was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
SVASD is a rare adult congenital heart disease which permits shunting of blood from the systemic to the pulmonary circulation , causing excessive blood flow to the lungs. Until now, open heart surgical repair was the gold standard approach to dealing with this condition but is necessarily invasive. Covered stent implantation is a recently developed interventional procedure that can replace open heart surgery in some of these patients. However, according to the study authors, there is no ideal stent often leaving physicians to modify existing stents and frequently ....

United States , City Of , United Kingdom , Eric Rosenthal , Society For Cardiovascular Angiography Interventions , Society For Cardiovascular Angiography , Sinus Venosus Atrial Septal Defect , Cardiovascular Angiography , Prof Eric Rosenthal , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , எரிக் ரோசென்டல் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி , இருதய ஆஞ்சியோகிராபி ,

Technology provides non-invasive treatment for congenital heart disease patients


 E-Mail
WASHINGTON, D.C., (April 30, 2021) - New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
About 40,000 infants are born with CHD every year in the United States and approximately one in five CHD patients have an abnormality of their right ventricular outflow tract (RVOT) . Prior to TPV technology, CHD patients were treated with invasive procedures such as open-heart surgery or opted for surgical valve replacement later in life. Th ....

United States , Thomas Jones , Society For Cardiovascular Angiography Interventions , Drug Administration , Society For Cardiovascular Angiography , Medtronic Harmony , Cardiovascular Angiography , Principal Investigator , Cardiac Catheterization Laboratories , Seattle Children , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் ஜோன்ஸ் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி , மெதிடிறோனிக் நல்லிணக்கம் , இருதய ஆஞ்சியோகிராபி , ப்ரிந்ஸிபல் புலனாய்வாளர் , இதய வடிகுழாய் ஆய்வகங்கள் , சீட்டில் குழந்தைகள் ,